CARTRIDGE DEVICE FOR A MEASURING SYSTEM FOR MEASURING VISCOELASTIC CHARACTERISTICS OF A SAMPLE LIQUID, A CORRESPONDING MEASURING SYSTEM, AND A CORRESPONDING METHOD
20190195898 ยท 2019-06-27
Assignee
Inventors
Cpc classification
B01L2300/0636
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0627
PERFORMING OPERATIONS; TRANSPORTING
B01L2200/10
PERFORMING OPERATIONS; TRANSPORTING
G01N11/00
PHYSICS
B01L3/502
PERFORMING OPERATIONS; TRANSPORTING
G01N33/86
PHYSICS
B01L2400/0475
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0861
PERFORMING OPERATIONS; TRANSPORTING
B01L3/52
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/087
PERFORMING OPERATIONS; TRANSPORTING
International classification
G01N33/86
PHYSICS
B01L3/00
PERFORMING OPERATIONS; TRANSPORTING
G01N11/00
PHYSICS
Abstract
The present invention is directed to a cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, in particular a blood sample, comprising a cartridge body having at least one measurement cavity formed therein and having at least one probe element arranged in said at least one measurement cavity for performing a test on said sample liquid; and a cover being attachable on said cartridge body; wherein said cover covers at least partially said at least one measurement cavity and forms a retaining element for retaining said probe element in a predetermined position within said at least one measurement cavity. The invention is directed to a measurement system and a method for measuring viscoelastic characteristics of a sample liquid.
Claims
1. A cartridge device for evaluation of hemostasis, comprising: a plurality of cavities each configured to receive blood of a test sample, each cavity comprising a reagent or combination of reagents; ductwork, including an inlet for receiving a test sample, wherein the ductwork is in communication with each of the plurality of cavities, whereby each of the plurality of cavities is configured to receive, via the ductwork, a portion of the test sample a first cavity of the plurality of cavities comprising a first reagent or a first combination of reagents that interact with the blood received therein, wherein the first reagent, or a reagent included in the first combination of reagents, is an activator of coagulation; a second cavity of the plurality of cavities comprising a second combination of reagents that interact with blood of the test sample received therein, the second combination including an activator of coagulation and one or more reagents configured for suppressing thrombocyte function; and an interrogation device that measures blood clot firmness of the test sample or other parameters dependent thereon.
2. (canceled)
3. The device of claim 1, wherein the activator of coagulation of the first cavity and the activator of coagulation of the second cavity are one or more reagents configured for extrinsic activation of the coagulation cascade.
4. The device of claim 3, wherein a third cavity of the plurality of cavities comprises one or more reagents configured for intrinsic activation of the coagulation cascade.
5. The device of claim 4, wherein the one or more reagents configured for suppressing thrombocyte function include cytochalasin D.
6. The device of claim 4 wherein the one or more reagents configured for intrinsic activation of the coagulation cascade include a Hagemann factor.
7. The device of claim 4, wherein a fourth cavity of the plurality of cavities comprises one or more reagents configured for testing platelet aggregometry.
8. The device of claim 3, wherein the one or more reagents configured for suppressing thrombocyte function include cytochalasin D.
9. The device of claim 1, wherein the one or more reagents configured for suppressing thrombocyte function include cytochalasin D.
10. The device of claim 1, wherein the device is a cartridge configured for use in conjunction with a measuring system.
11. The device of claim 10, wherein the measuring system is configured to measure over time changes in blood clot firmness of the portion of the test sample in each of the cavities or other parameters dependent thereon.
12. The device of claim 11, wherein the measuring system is configured to receive the cartridge in a pre-determined orientation whereby the cartridge in the pre-determined orientation is aligned with a plurality of detectors, each of the plurality of detectors associated with a respective cavity.
13. The device of claim 11, wherein the measuring system includes control apparatus configured for interacting with the cartridge to move the test sample through the cartridge.
14. The device of claim 11, wherein the changes in the blood clot firmness of the portion of the test sample or the other parameters dependent thereon are measured by the measuring system detecting changes in amplitude of an oscillating motion excitation of the portion of the test sample.
15. The device of claim 14, wherein the oscillating motion excitation of the portion of the test sample is achieved mechanically via a plurality of probes interfaced with the measuring system.
16. The device of claim 1, wherein the one or more reagents within each of the plurality of cavities are in a solid form.
17. The device of claim 1, further comprising a housing, wherein each of the plurality of cavities are at least partially defined by the housing.
18. The device of claim 11, wherein the device is configured for use with a single test sample.
19. The device of claim 18, further comprising a fluid pathway having an inlet for receiving a test sample, wherein the fluid pathway is in communication with at least one cavity to deliver the test sample, or a portion thereof, to one or more of the cavities.
20. The device of claim 19, wherein the fluid pathway further comprises a channel in communication with a least one cavity, and wherein sample delivered from the channel into the cavity results in mixing of at least a portion of the sample and the reagent within the cavity.
21. The device of claim 1, wherein the second cavity comprises a combination of reagents that includes a reagent comprised by the first cavity.
22. (canceled)
23. The device of claim 1, wherein the interrogation device is configured to measure changing in elastic properties of the test sample.
24. The device of claim 1, wherein the device is configured to be interrogated to determine a hemostatic parameter of the test sample.
25. The device of claim 1, wherein the interrogation device is configured to perform a viscoelastic method of testing.
26. The device of claim 1, wherein the interrogation device is configured to continuously measure the blood clot firmness or the other parameters dependent thereon from the formation of the first fibrin fibers until the dissolution of the blood clot by fibrinolysis.
27. The device of claim 1, wherein the interrogation device is configured to measure a maximum clot firmness.
28. The device of claim 1, wherein the interrogation device is configured to measure a rate of clot formation.
29. The device of claim 1, wherein the interrogation device is configured measure blood clot firmness during multiple interlinked processes including coagulation activation, thrombin formation, fibrin formation and polymerization, platelet activation and fibrin-platelet interaction and fibrinolysis.
30. The device of claim 1, wherein the interrogation device is configured for thromboelastometry or thromboelastography.
31. The device of claim 1, wherein the interrogation device is configured to generate a curve representing changes in clot firmness over time.
32. The device of claim 1, wherein the ductwork defines a fluid pathway includes an inlet channel, a first channel, and a second channel, wherein the inlet channel is in communication with the inlet, wherein the first channel is in communication with the inlet channel and at least with the first cavity, and wherein the second channel is in communication with the inlet channel and at least with the second cavity.
33. The device of claim 32, wherein a pump is configured to move the sample through the fluid pathway and distribute the sample from the inlet to the plurality of cavities.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0061] The figures are showing the following:
[0062]
[0063]
[0064]
[0065]
[0066]
[0067]
[0068]
[0069]
[0070]
[0071]
[0072]
[0073]
[0074]
[0075]
[0076]
[0077]
[0078]
[0079]
[0080]
[0081]
[0082]
[0083]
[0084]
[0085]
DESCRIPTION OF EXEMPLARY EMBODIMENTS
[0086] Parts and components having same functions are depicted with same references.
[0087] Prior to a detailed description of the preferred embodiments the basic features and a basic practical implementation are summoned as follows. All embodiments refer to a cartridge device 50 (see
[0088] A first embodiment of a cartridge device 50 of the invention will be described with reference to
[0089] In this embodiment the receiving cavity 16 consists of a cavity within the cartridge device 50. The sample liquid 1 can be applied by means of a syringe, pipette etc, e.g. through a self sealing cap shown as a receiving cavity cover 33a in
[0090] In an alternative embodiment the reagent cavity 19 is integral formed with the pump means 18 and/or with the measurement cavity 20 and/or with the ductwork. The transport of the sample liquid 1 can be controlled by said control apparatus.
[0091]
[0092] It is apparent to a person skilled in the art that in order to achieve a maximum benefit for a user different types of tests can be combined in one cartridge device 50.
[0093] In a preferred embodiment the cartridge device 50 comprises four arrangements of
[0094] Regarding e.g. blood coagulation there are different reagents available which activate or suppress different parts of the coagulation cascade. Pentapharm GmbH (Munich, Germany) for example amongst others provide tests for intrinsic and extrinsic activation of a blood sample (INTEM or EXTEM respectively), and also a test for extrinsic activation in which the thrombocyte function is suppressed by administration of cytochalasin D (FIBTEM). It is state of the art that it is possible by wise combination of such tests to be able to determine very precisely at which point within the coagulation cascade a problem occurs. This is of great importance in order to determine a proper medication. By comparison of the results on an EXTEM test of a pathologic sample to those of a FIBTEM test of the same sample it is possible to e.g. precisely determine if a coagulation disorder results from lack of fibrinogen or a malfunction of platelets. Generally, there are different typical medical scenarios in which coagulation disorders are very likely to occur. For example coagulation disorders occurring during liver transplantation are merely caused by lack of certain coagulation factors etc., while coagulation disorders during open heart surgery are most likely due to the influence of heparin. This means basically that different medical settings require different coagulation tests. Referring to
[0095] It is important to note that the cartridge devices 50 of the described embodiments are suitable for different diagnostic tests like thromboelastometry, thromboelastography, platelet aggregometry and others. Depending on which type of test or tests the cartridge device 50 is designed for, there are different additional parts required which interact with the sample during measurement and/or an external control apparatus. Possible adaptations for thromboelastometry and platelet aggregometry are described below.
[0096]
[0097] The probe element 22 comprises the probe pin 3 (see
[0098] The probe element 22 is arranged in the measurement cavity 20 of the cartridge body 30 of the cartridge device 50 as shown in
[0099] During attaching the cartridge device 50 to the measuring system 40 (see also
[0100] It is also possible to insert the insert section 6a of the shaft 6 into the connector section 26 of the probe element 22 and push the probe element 22 down until its bottom contacts the bottom of the measurement cavity 20, 20 ensuring that the insert section 6a is completely inserted into the connector section 26. Then the shaft 6 will be moved up into the measuring resp. working position of the probe element 22 as shown in
[0101]
[0102] Now a third embodiment of the cartridge device 50 will be described with reference to
[0103]
[0104] The cartridge device 50 of this example is equipped with the ductwork 13 and 15. The ducts are formed with an diameter of approximately 1 mm in this embodiment. The ductwork requires that the cartridge device 50 comprises two parts: the cartridge body 30 and the cover 31, which are glued or welded together to obtain a leak-proof device. The cartridge body 30 is relative rigid and the cover 31 is formed as an elastic part. So it is possible to integrate the pump means 18 into the cover 31. Moreover, the cover 31 covers the receiving cavity 16 with the receiving cavity cover 33a and forms a type of liner wall 33 and a separation wall 34 forming an inlet for the inlet duct 13 within the receiving cavity 16. The receiving cavity cover 33a might act as a self seal for injection of a sample liquid 1 by a syringe for example. The cover 31 forms top parts of the ductwork 13 an 15 and a cover of the measurement cavity 20 (see also
[0105] In this embodiment a reagent cavity 19, 19 is formed, e.g. by sections of the ductwork or/and the pump means 18, 18 in which the reagents can be stored resp. deposited, especially on the pump cavity bottom 36a, for example.
[0106] The pump means 18 will now be described with reference to
[0107]
[0108] In this example the pump cavity 36 is connected to the inlet duct 13 via an inlet valve 37 and to the outlet valve via an outlet valve 38. Actuation of the pump membrane 35 (shown in
[0109] An external force exerted on the pump membrane 35 increase the pressure within the pump cavity 36 and opens outlet valve 38 and closes inlet valve 37. Releasing the external force the elastic pump membrane 35 returns into the position shown in
[0110] Now the measuring system 40 according to the invention is described in an embodiment with reference to
[0111]
[0112] The measuring system 40 comprises an interface element 41 to which the cartridge device 50 is attached and fixed. The interface element 41 is shown in
[0113]
[0114] Thus it is possible to e.g. arrange a reagent receptacle 19b in a blister receptacle e.g. as shown in
[0115] It is also possible to insert reagent receptacles into provided cavities being connected to the ductwork. The reagents can be designed as globules with an appropriate diameter so that they cannot flow through openings into the ductwork before being dissolved by the sample liquid.
[0116]
LIST OF REFERENCE NUMERALS
[0117] 1 Sample liquid [0118] 2 Cup [0119] 3 Probe pin [0120] 4 Torsion wire [0121] Rotation axis [0122] 6 Shaft [0123] 6a Insert section [0124] 7 Bearing [0125] 8 Mirror [0126] 9 Spring [0127] 10 Detecting means [0128] 11 Base plate [0129] 12 Cup holder [0130] 13, 13 Inlet duct [0131] 14, 14 Intermediate duct [0132] 15, 15 Outlet duct [0133] 16, 16 Receiving cavity [0134] 17 Branch duct [0135] 18, 18 Pump means [0136] 19,19 Reagent cavity [0137] 19a, 19a Regent cavity bottom [0138] 19b Reagent receptacle [0139] 20, 20 Measurement cavity [0140] 21, 21 Reagent [0141] 22, 22 Probe element [0142] 23 Intermediate section [0143] 24 Flange [0144] 25 Fixing section [0145] 26 Connector section [0146] 27 Insertion guide [0147] 28 Groove [0148] 29 Dimple [0149] 29a Nose [0150] 30 Cartridge body [0151] 31 Cover [0152] 32 Fixing means [0153] 32a Opening [0154] 33 Wall [0155] 33a Receiving cavity cover [0156] 34 Separation wall [0157] 35 Pump membrane [0158] 36 Pump cavity [0159] 36a Pump cavity bottom [0160] 37 Inlet valve [0161] 38 Outlet valve [0162] 39 Flow direction [0163] 40 Measuring system [0164] 41 Interface element [0165] 42 Pump access [0166] 43 inlet opening [0167] 44 Shaft passage [0168] 44a Passage hole [0169] 45 Reagent cover opening [0170] 46 Retaining ring [0171] 47 Frame [0172] 48 Bottom foil [0173] 49 Blister cover [0174] 50 Cartridge device